Provenance du réseau au premier degré de Jerry Yang
Entité | Type d'entité | Industrie | |
---|---|---|---|
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd.
6
| Subsidiary | Investment Managers | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jerry Yang via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member | |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SK Holdings, Inc.
SK Holdings, Inc. BroadcastingConsumer Services Part of Match Group, Inc., SK Holdings, Inc. is a company based in New York, NY. | Broadcasting | Corporate Officer/Principal | |
CSL LIMITED | Biotechnology | Director/Board Member | |
MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
University of Virginia | College/University | Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Masters Business Admin | |
COCHLEAR LIMITED | Medical Specialties | Director/Board Member | |
ASPEN PHARMACARE HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
University of Cambridge | College/University | Graduate Degree | |
Eli Lilly Ranbaxy Ltd.
Eli Lilly Ranbaxy Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Ranbaxy Ltd. is an Indian company that manufactures and sells pharmaceutical products. The company is based in New Delhi, India. The company was founded in 1993. Edgard Olaizola has been the CEO of the company since 2013. Eli Lilly Ranbaxy was acquired by Eli Lilly & Co. from Ranbaxy Laboratories Ltd. on August 08, 2001 for $17 million. | Pharmaceuticals: Major | Sales & Marketing | |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Loughborough University | College/University | Undergraduate Degree | |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Analyst | |
Nankai University | College/University | Doctorate Degree | |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lilly Deutschland GmbH
Lilly Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly Deutschland GmbH is a pharmaceutical company based in Bad Homburg, Germany. The German company manufactures pharmaceutical products. The company was founded in 1960 by Eli Lilly. The CEO is Kadir Tepebasi. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Doctorate Degree | |
GENEXINE, INC. | Biotechnology | Chief Executive Officer | |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lilly Pharma Holding GmbH | Corporate Officer/Principal | ||
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Duke-NUS Graduate Medical School Singapore | College/University | Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman | |
Korea Evaluation Institute of Industrial Technology
Korea Evaluation Institute of Industrial Technology Miscellaneous Commercial ServicesCommercial Services Korea Evaluation Institute of Industrial Technology operates as a research institute to develop technology for domestic industries. The company is based in Daegu, South Korea. The South Korean company is ultimately controlled by the Government of South Korea. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lilly Ilaç Ticaret Ltd. Sti.
Lilly Ilaç Ticaret Ltd. Sti. Pharmaceuticals: MajorHealth Technology Lilly Ilaç Ticaret Ltd Sti engages in the development of pharmaceutical products. It offers medicaments in the areas of diabetes, endocrinology, central nervous system diseases, psoriasis, oncology, and men’s health. The company was founded on November 5, 1993 and is headquartered in Istanbul, Turkey. | Pharmaceuticals: Major | Corporate Officer/Principal | |
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Biotechnology | Director/Board Member | |
C-Bridge Capital Partners LLC | Corporate Officer/Principal | ||
Alfasigma SpA
Alfasigma SpA Pharmaceuticals: MajorHealth Technology Alfasigma SpA operates as a holding company with interests in companies in the pharmaceutical industries. The company was founded on May 14, 2015 and is headquartered in Bologna, Italy. | Pharmaceuticals: Major | Director/Board Member | |
EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
TargTex SA
TargTex SA Pharmaceuticals: MajorHealth Technology TargTex SA is a Portuguese pharmaceutical company that manufactures pharmaceutical products. The company is based in Lisbon, Portugal. The company was founded by Joao Seixas. | Pharmaceuticals: Major | Director/Board Member | |
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Biotechnology | Director/Board Member | |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Pharmaceuticals: Major | Chairman | |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
InxMed Biotechnology Nanjing Co., Ltd.
InxMed Biotechnology Nanjing Co., Ltd. BiotechnologyHealth Technology InxMed Biotechnology Nanjing Co., Ltd. is a clinical-stage biotech company established in 2018, dedicated to developing innovative therapies to overcome treatment resistance, especially anti PD-1/PD-L1 resistance. InxMed is based in Nanjing, China, and has teams located in Shanghai and Beijing, with hubs in San Francisco and Melbourne. The Chinese company's innovations are inspired by patients and driven by in-depth understanding of disease biology and pharmacology. InxMed has raised tens of millions of US dollars in series A round financing and has an integrated high-caliber research and clinical development team across China, the US, and Australia. The company has built a unique innovative pipeline through its own discovery research and development and collaborative research and development. The company was founded in 2018 by Fei Cao and Zai Qi Wang, with Zai Qi Wang serving as the CEO since then. | Biotechnology | Director/Board Member | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
C-Bridge Capital LLC
C-Bridge Capital LLC Investment ManagersFinance C-Bridge Capital LLC (C-Bridge Capital) is a venture capital subsidiary of CBC Group founded in 2019 by Fu Wei. The firm is headquartered in New York.. | Investment Managers | Private Equity Investor | |
Vifor Pharma, Inc.
Vifor Pharma, Inc. Medical/Nursing ServicesHealth Services Vifor Pharma, Inc. is an American company that specializes in iron deficiency, nephrology, and cardio-renal therapies. The company is based in Redwood. | Medical/Nursing Services | Chief Executive Officer | |
ENSEM Therapeutics, Inc.
ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ENSEM Therapeutics, Inc. is a drug discovery and development company that specializes in developing small molecule precision medicines for oncology. The company is based in Waltham, MA. The company leverages its unique Kinetic Ensemble® platform to develop innovative drugs. The company has a potential oral CDK2 inhibitor, PI3K?, and a number of early-stage discovery programs at various stages of maturity launched with their Kinetic Ensemble® platform. ENSEM Therapeutics was founded by Shenfang Jin, Qi Zhang, Cheng Luo, and Shenfang Jin has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
Eli Lilly Australia Pty Ltd.
Eli Lilly Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly Australia Pty Ltd. manufactures and supplies pharmaceutical products. It develops medicines for diabetes, cancer, immunology, and pain. The company was founded in 1960 and is headquartered in West Ryde, Australia. | Pharmaceuticals: Major | Sales & Marketing | |
Portola Capital Partners
Portola Capital Partners Investment ManagersFinance Portola Capital Partners is a private equity firm founded in 1992. The firm is headquartered in Silicon Valley, California. | Investment Managers | Private Equity Investor |
Statistiques
Internationale
Etats-Unis | 20 |
Royaume-Uni | 7 |
Chine | 7 |
Australie | 4 |
Suisse | 3 |
Sectorielle
Health Technology | 35 |
Consumer Services | 9 |
Finance | 5 |
Commercial Services | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 20 |
Corporate Officer/Principal | 17 |
Private Equity Investor | 7 |
Chief Executive Officer | 5 |
Private Equity Analyst | 4 |
Relations les plus connectées
Insiders | |
---|---|
Shah Hussain | 25 |
Michael Keyoung | 17 |
Sean Cao | 11 |
James Cen Bonsor | 3 |
Monica Jiang | 1 |
Mars Lin | 1 |
- Bourse
- Insiders
- Jerry Yang
- Connexions Sociétés